Primary Cytoreduction and Survival for Patients With Less-Common Epithelial Ovarian Cancer

Koji Matsuo; Ling Chen; Maximilian Klar; Lynda D Roman; Anil K Sood; David M Gershenson; Jason D Wright

doi:10.1001/jamanetworkopen.2024.17775

Primary Cytoreduction and Survival for Patients With Less-Common Epithelial Ovarian Cancer

JAMA Netw Open. 2024 Jun 3;7(6):e2417775. doi: 10.1001/jamanetworkopen.2024.17775.

Authors

Koji Matsuo^{1

2}, Ling Chen³, Maximilian Klar⁴, Lynda D Roman^{1

2}, Anil K Sood⁵, David M Gershenson⁵, Jason D Wright³

Affiliations

¹ Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, Los Angeles.
² Norris Comprehensive Cancer Center, University of Southern California, Los Angeles.
³ Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York.
⁴ Department of Obstetrics and Gynecology, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
⁵ Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston.

No abstract available

Plain language summary

This cohort study examines the association between primary cytoreduction status and survival for patients with less-common, advanced-stage epithelial ovarian carcinoma.

MeSH terms

Adult
Aged
Carcinoma, Ovarian Epithelial* / mortality
Carcinoma, Ovarian Epithelial* / surgery
Cytoreduction Surgical Procedures* / methods
Female
Humans
Middle Aged
Ovarian Neoplasms* / mortality
Ovarian Neoplasms* / surgery
Retrospective Studies